New immuno-PCR assay for detection of low concentrations of shiga toxin 2 and its variants

Journal of Clinical Microbiology

Volumn 46, Issue 4, 2008, Pages 1292-1297

  Zhang, Wenlan ^a   Bielaszewska, Martina ^a   Pulz, Matthias ^b   Becker, Karsten ^a   Friedrich, Alexander W ^a   Karch, Helge ^a   Kuczius, Thorsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Lower Saxony Governmental Institute of Public Health   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; STREPTAVIDIN; VEROTOXIN 2;

AGAR GEL ELECTROPHORESIS; ARTICLE; BACTERIAL VIRULENCE; ENZYME IMMUNOASSAY; FECES CULTURE; GENE AMPLIFICATION; IMMUNOASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; ESCHERICHIA COLI; EVALUATION; FECES; GENETIC VARIABILITY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; SENSITIVITY AND SPECIFICITY;

ESCHERICHIA COLI;

ESCHERICHIA COLI; FECES; HUMANS; IMMUNOENZYME TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SHIGA TOXIN 2; VARIATION (GENETICS);

EID: 42449116191     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02271-07     Document Type: Article

References (52)

1. Adler, M., R. Wacker, and C. M. Niemeyer. 2003. A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins. Biochem. Biophys. Res. Commun. 308:240-250.
2. Adler, M., S. Schulz, R. Fischer, and C. M. Niemeyer. 2005. Detection of rotavirus from stool samples using a standardized immuno-PCR ("Imperacer") method with end-point and real-time detection. Biochem. Biophys. Res. Commun. 333:1289-1294.
3. Banatvala, N., P. M. Griffin, K. D. Greene, T. J. Barrett, W. F. Bibb, J. H. Green, and J. G. Wells. 2001. The United States national prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical, and epidemiologic findings. J. Infect. Dis. 183:1063-1070.
4. Barletta, J. M., D. C. Edelman, and N. T. Constantine. 2004. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen. Am. J. Clin. Pathol. 122:20-27.
5. Bellin, T., M. Pulz, A. Matussek, H. G. Hempen, and F. Gunzer. 2001. Rapid detection of enterohemorrhagic Escherichia coli by real-time PCR with fluorescent hybridization probes. J. Clin. Microbiol. 39:370-374.
6. Beutin, L., H. Steinruck, G. Krause, K. Steege, S. Haby, G. Hultsch, and B. Appel. 2007. Comparative evaluation of the Ridascreen verotoxin enzyme immunoassay for detection of Shiga-toxin producing strains of Escherichia coli (STEC) from food and other sources. J. Appl. Microbiol. 102:630-639.
7. Bielaszewska, M., A. W. Friedrich, T. Aldick, R. Schurk-Bulgrin, and H. Karen. 2006. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin. Infect. Dis. 43:1160-1167.
8. Bielaszewska, M., R. Köck, A. W. Friedrich, C. von Eiff, L. B. Zimmerhackl, H. Karch, and A. Mellmann. 2007. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS ONE 2:e1024.
9. Brooks, J. T., E. G. Sowers, J. G. Wells, K. D. Greene, P. M. Griffin, R. M. Hoekstra, and N. A. Strockbine. 2005. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192:1422-1429.
10. Centers for Disease Control and Prevention. 2007. Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli - Connecticut, 2000-2005. MMWR Morb. Mortal. Wkly. Rep. 56:29-31.
11. Chao, H. Y., Y. C. Wang, S. S. Tang, and H. W. Liu. 2004. A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A. Toxicon 43:27-34.
12. Donohue-Rolfe, A., M. A. Kelley, M. Bennish, and G. T. Keusch. 1986. Enzyme-linked immunosorbent assay for shigella toxin. J. Clin. Microbiol. 24:65-68.
13. Elliott, E. J., R. M. Robins-Browne, E. V. O'Loughlin, V. Bennett-Wood, J. Bourke, P. Henning, G. G. Hogg, J. Knight, H. Powell, D. Redmond, and Contributors to the Australian Paediatric Surveillance Unit. 2001. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch. Dis. Child. 85:125-131.
14. Fischer, A., C. von Eiff, T. Kuczius, K. Omoe, G. Peters, and K. Becker. 2007. A quantitative real-time immuno-PCR approach for detection of staphylococcal enterotoxins. J. Mol. Med. 85:461-469.
15. Friedrich, A. W., M. Bielaszewska, W. Zhang, M. Pulz, T. Kuczius, A. Ammon, and H. Karch. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185:74-84.
16. Hendrickson, E. R., T. M. Truby, R. D. Joerger, W. R. Majarian, and R. C. Ebersole. 1995. High sensitivity multianalyte immunoassay using covalent DNA-labeled antibodies and polymerase chain reaction. Nucleic Acids Res. 23:522-529.
17. Jelacic, J. K., T. Damrow, G. S. Chen, S. Jelacic, M. Bielaszewska, M. Ciol, H. M. Carvalho, A. R. Melton-Celsa, A. D. O'Brien, and P. I. Tarr. 2003. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J. Infect. Dis. 188:719-729.
18. Johnson, K. E., C. M. Thorpe, and C. L. Sears. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43:1587-1595.
19. Karch, H., and T. Meyer. 1989. Evaluation of oligonucleotide probes for identification of Shiga-like-toxin-producing Escherichia coli. J. Clin. Microbiol. 27:1180-1186.
20. Karch, H., and T. Meyer. 1989. Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction. J. Clin. Microbiol. 27:2751-2757.
21. Karch, H., N. A. Strockbine, and A. D. O'Brien. 1986. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin-producing strains by colony blot assay. FEMS Microbiol. Lett. 35:141-145.
22. Karch, H., P. I. Tarr, and M. Bielaszewska. 2005. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295:405-418.
23. Karmali, M. A., M. Petric, and M. Bielaszewska. 1999. Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli. J. Clin. Microbiol. 37:396-399.
24. Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782.
25. Kater, A. P., A. M. Westermann, M. R. de Groot, A. E. von dem Borne, and E. J. Kuijper. 2000. Toxin-mediated haemolytic uraemic syndrome without diarrhoea. J. Intern. Med. 248:263-265.
26. Klein, E. J., J. R. Stapp, C. R. Clausen, D. R. Boster, J. G. Wells, X. Qin, D. L. Swerdlow, and P. I. Tarr. 2002. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J. Pediatr. 141:172-177.
27. Kuczius, T., M. Bielaszewska, A. W. Friedrich, and W. Zhang. 2004. A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli. Mol. Nutr. Food Res. 48:515-521.
28. Manning, S. D., R. T. Madera, W. Schneider, S. E. Dietrich, W. Khalife, W. Brown, T. S. Whittam, P. Somsel, and J. T. Rudrik. 2007. Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001-2005. Emerg. Infect. Dis. 13:318-321.
29. McKie, A., D. Samuel, B. Cohen, and N. A. Saunders. 2002. A quantitative immuno-PCR assay for the detection of mumps-specific IgG. J. Immunol. Methods 270:135-141.
30. Meisen, I., A. W. Friedrich, H. Karch, U. Witting, J. Peter-Katalinic, and J. Muthing. 2005. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. Rapid Commun. Mass Spectrom. 19:3659-3665.
31. Mellmann, A., M. Bielaszewska, L. B. Zimmerhackl, R. Prager, D. Harmsen, H. Tschape, and H. Karch. 2005. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin. Infect. Dis. 41:785-792.
32. Melton-Celsa, A. R., S. C. Darnell, and A. D. O'Brien. 1996. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect. Immun. 64:1569-1576.
33. Muniesa, M., J. Recktenwald, M. Bielaszewska, H. Karch, and H. Schmidt. 2000. Characterization of a Shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin. Infect. Immun. 68:4850-4855.
34. Piérard, D., G. Muyldermans, L. Moriau, D. Stevens, and S. Lauwers. 1998. Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J. Clin. Microbiol. 36:3317-3322.
35. Pulz, M., A. Matussek, M. Monazahian, A. Tittel, E. Nikolic, M. Hartmann, T. Bellin, J. Buer, and F. Gunzer. 2003. Comparison of a Shiga toxin enzyme-linked immunosorbent assay and two types of PCR for detection of Shiga toxin-producing Escherichia coli in human stool specimens. J. Clin. Microbiol. 41:4671-4675.
36. Reischl, U., M. T. Youssef, J. Kilwinski, N. Lehn, W. L. Zhang, H. Karch, and N. A. Strockbine. 2002. Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 40:2555-2565.
37. Saito, K., D. Kobayashi, M. Sasaki, H. Araake, T. Kida, A. Yagihashi, T. Yajima, H. Kameshima, and N. Watanabe. 1999. Detection of human serum tumor necrosis factor-alpha in healthy donors, using a highly sensitive immuno-PCR assay. Clin. Chem. 45:665-669.
38. Sandvig, K. 2001. Shiga toxins. Toxicon 39:1629-1635.
39. Schmidt, H., J. Scheef, S. Morabito, A. Caprioli, L. H. Wieler, and H. Karch. 2000. A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl. Environ. Microbiol. 66:1205-1208.
40. - strain E32511. Infect. Immun. 59:1065-1073.
41. Sonntag, A. K., E. Zenner, H. Karch, and M. Bielaszewska. 2005. Pigeons as a possible reservoir of Shiga toxin 2f-producing Escherichia coli pathogenic to humans. Berl. Munch. Tierarztl. Wochenschr. 118:464-470.
42. Sonntag, A. K., M. Bielaszewska, A. Mellmann, N. Dierksen, P. Schierack, L. H. Wieler, M. A. Schmidt, and H. Karch. 2005. Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Appl. Environ. Microbiol. 71:8855-8863.
43. Sonntag, A. K., R. Prager, M. Bielaszewska, W. Zhang, A. Fruth, H. Tschape, and H. Karch. 2004. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J. Clin. Microbiol. 42:954-962.
44. Starr, M., V. Bennett-Wood, A. K. Bigham, T. F. de Koning-Ward, A. M. Bordun, D. Lightfoot, K. A. Bettelheim, C. L. Jones, and R. M. Robins-Browne. 1998. Hemolytic-uremic syndrome following urinary tract infection with enterohemorrhagic Escherichia coli: case report and review. Clin. Infect. Dis. 27:310-315.
45. Strockbine, N. A., L. R. Marques, J. W. Newland, H. W. Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encodes antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
46. Tarr, P. I., L. S. Fouser, A. E. Stapleton, R. A. Wilson, H. H. Kim, J. C. Vary, Jr., and C. R. Clausen. 1996. Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. N. Engl. J. Med. 335:635-638.
47. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome. Lancet 365:1073-1086.
48. Tozzi, A. E., A. Caprioli, F. Minelli, A. Gianviti, L. De Petris, A. Edefonti, G. Montini, A. Ferretti, Z. De Palo, M. Gaido, and G. Tizzoni; Hemolytic Uremic Syndrome Study Group. 2003. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg. Infect. Dis. 9:106-108.
49. Yam, W. C., D. N. Tsang, T. L. Que, M. Peiris, W. H. Seto, and K. Y. Yuen. 1998. A unique strain of Escherichia coli O157:H7 that produces low verocytotoxin levels not detected by use of a commercial enzyme immunoassay kit. Clin. Infect. Dis. 27:905-906.
50. 1c) in Escherichia coli strains isolated from humans. J. Clin. Microbiol. 40:1441-1446.
51. Zhang, W., M. Bielaszewska, A. W. Friedrich, T. Kuczius, and H. Karch. 2005. Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli. Appl. Environ. Microbiol. 71:558-561.
52. Zhang, W., A. Mellmann, A. K. Sonntag, L. Wieler, M. Bielaszewska, H. Tschape, H. Karch, and A. W. Friedrieh. 2007. Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. Int. J. Med. Microbiol. 297:17-26.